| Debt and Finance Leases |
8. Debt and Finance Leases Debt and finance leases included the following: | | | | | | | | | | | | | June 28, 2025 | | December 31, 2024 | ABL Credit Facility due November 2029: $116 million net availability, bearing interest of 6.4% (4.4% adjusted SOFR plus 2.0% margin) at June 28, 2025 | $ | 12,450 | | | $ | — | | 2029 Term Loan due October 2029: bearing interest of 11.3% (4.3% three-month Term SOFR plus 7.0% margin) at June 28, 2025 | 698,250 | | | 700,000 | | 5.50% CAD-based term loan due April 2028 | 19,537 | | | 21,184 | | BioNova debt(a) | 22,524 | | | 21,120 | | Other loans(b) | 34,968 | | | 32,536 | | | Short-term factoring facility | 1,865 | | | 2,304 | | | Finance lease obligations | 693 | | | 921 | | | Total principal payments due | 790,287 | | | 778,065 | | | Less: unamortized premium, discount and issuance costs | (44,593) | | | (48,242) | | | Total debt | 745,694 | | | 729,823 | | | Less: debt due within one year | (25,342) | | | (23,379) | | | Long-term debt | $ | 720,352 | | | $ | 706,444 | |
(a)Consists of green loans associated with the France bioethanol plant, part of the net assets contributed by the Company to its subsidiary, BioNova. (b)Consist of loans for energy projects in France. As of June 28, 2025, there were no borrowings outstanding under the BioNova Term Loan. Covenants and Debt Maturity As of June 28, 2025, the Company was in compliance with all covenants under its debt agreements and the Company’s debt principal payments, excluding finance lease obligations, were due as follows: | | | | | | | Remainder of 2025 | $ | 28,690 | | | 2026 | 22,053 | | | 2027 | 20,529 | | | 2028 | 18,841 | | | 2029 | 681,077 | | | Thereafter | 18,404 | | | Total debt principal payments | $ | 789,594 | |
|